Practical modifications to the Time-to-Event Continual Reassessment Method for phase I cancer trials with fast patient accrual and late-onset toxicities

Por Polley, Mei-Yin C.
Publicado em 2011

Development of omics-based clinical tests for prognosis and therapy selection: The challenge of achieving statistical robustness and clinical utility

Por McShane, Lisa M., Polley, Mei-Yin C.
Publicado no Clin Trials (2013)

Randomized Phase II Trial Designs With Biomarkers

Por Freidlin, Boris, McShane, Lisa M., Polley, Mei-Yin C., Korn, Edward L.
Publicado em 2012

Two-Stage Adaptive Cutoff (TACO) Design for Building and Validating a Prognostic Biomarker Signature

Por Polley, Mei-Yin C., Polley, Eric C., Huang, Erich P., Freidlin, Boris, Simon, Richard
Publicado no Stat Med (2014)

Comparison of confidence interval methods for an intra-class correlation coefficient (ICC)

Por Ionan, Alexei C, Polley, Mei-Yin C, McShane, Lisa M, Dobbin, Kevin K
Publicado no BMC Med Res Methodol (2014)

Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide

Por Polley, Mei-Yin C., Lamborn, Kathleen R., Chang, Susan M., Butowski, Nicholas, Clarke, Jennifer L., Prados, Michael
Publicado em 2010

Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma

Por Polley, Mei-Yin C., Lamborn, Kathleen R., Chang, Susan M., Butowski, Nicholas, Clarke, Jennifer L., Prados, Michael
Publicado em 2011

Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers

Por Polley, Mei-Yin C., Freidlin, Boris, Korn, Edward L., Conley, Barbara A., Abrams, Jeffrey S., McShane, Lisa M
Publicado em 2013

Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma

Por Essock-Burns, Emma, Lupo, Janine M., Cha, Soonmee, Polley, Mei-Yin, Butowski, Nicholas A., Chang, Susan M., Nelson, Sarah J.
Publicado em 2011

Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme

Por Li, Yan, Lupo, Janine M., Polley, Mei-Yin, Crane, Jason C., Bian, Wei, Cha, Soonmee, Chang, Susan, Nelson, Sarah J.
Publicado em 2011

Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme(†)

Por Khayal, Inas S., Polley, Mei-Yin C., Jalbert, Llewellyn, Elkhaled, Adam, Chang, Susan M., Cha, Soonmee, Butowski, Nicholas A., Nelson, Sarah J.
Publicado em 2010

C-C4-02: Using a Natural Language Processor to Remove All Elements of Personal Health Information (PHI) to Deidentify Clinical Annotations for the Specimen Retrieval System (SRS)

Por Glass, Andrew, Taube, Sheila, McMurry, Andrew, Eddy, Chris, La Chance, Pierre-Andre, McShane, Lisa, Polley, Mei-Yin, Kohane, Isaac
Publicado em 2011

Quality of life in low-grade glioma patients receiving temozolomide

Por Liu, Raymond, Solheim, Karla, Polley, Mei-Yin, Lamborn, Kathleen R., Page, Margaretta, Fedoroff, Anne, Rabbitt, Jane, Butowski, Nicholas, Prados, Michael, Chang, Susan M.
Publicado em 2009

Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma

Por Phillips, Joanna J., Huillard, Emmanuelle, Robinson, Aaron E., Ward, Anna, Lum, David H., Polley, Mei-Yin, Rosen, Steven D., Rowitch, David H., Werb, Zena
Publicado em 2012

Functional mapping–guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival

Por Chang, Edward F., Clark, Aaron, Smith, Justin S., Polley, Mei-Yin, Chang, Susan M., Barbaro, Nicholas M., Parsa, Andrew T., McDermott, Michael W., Berger, Mitchel S.
Publicado em 2010

Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase I study(†)

Por Butowski, Nicholas, Chang, Susan M., Lamborn, Kathleen R., Polley, Mei Yin, Parvataneni, R., Hristova-Kazmierski, Maria, Musib, Luna, Nicol, Steven J., Thornton, Donald E., Prados, Michael D.
Publicado em 2010

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

Por Srinivasan, Radhika, Phillips, Joanna J., VandenBerg, Scott R., Polley, Mei-Yin C., Bourne, Gabriela, Au, Alvin, Pirzkall, Andrea, Cha, Soonmee, Chang, Susan M., Nelson, Sarah J.
Publicado em 2010

Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study

Por Mueller, Sabine, Polley, Mei-Yin, Lee, Benjamin, Kunwar, Sandeep, Pedain, Christoph, Wembacher-Schröder, Eva, Mittermeyer, Stephan, Westphal, Manfred, Sampson, John H., Vogelbaum, Michael A., Croteau, David, Chang, Susan M.
Publicado em 2010

Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide

Por Prasad, Gautam, Sottero, Theo, Yang, Xiaodong, Mueller, Sabine, James, C. David, Weiss, William A., Polley, Mei-Yin, Ozawa, Tomoko, Berger, Mitchel S., Aftab, Dana T., Prados, Michael D., Haas-Kogan, Daphne A.
Publicado em 2011

Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: Efficacy and underlying mechanisms

Por Mueller, Sabine, Yang, Xiaodong, Sottero, Theo L., Gragg, Ashley, Prasad, Gautam, Polley, Mei-Yin, Weiss, William A., Matthay, Katherine K., Davidoff, Andrew M., DuBois, Steven G., Haas-Kogan, Daphne A.
Publicado em 2011